Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Pfizer (NY: PFE)
40.71 USD  -0.10 (-0.25%)
Official Closing Price  /  Updated: 7:31 PM EDT, Aug 14, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 16,448,500
Open 40.84
Bid (Size) 40.54 (3)
Ask (Size) 40.79 (3)
Prev. Close 40.81
Today's Range 40.54 - 41.03
52wk Range 32.32 - 41.64
Shares Outstanding 5,849,571,048
Dividend Yield 3.29%
Performance
YTD
+11.72%
+11.72%
1 Month
+8.91%
+8.91%
3 Month
+14.07%
+14.07%
6 Month
+16.51%
+16.51%
1 Year
+22.22%
+22.22%
Top News
More News
Alnylam Gets An FDA Nod — But Pfizer, Others May Decimate It
Alnylam Pharmaceuticals crumbled Monday after U.S. officials approved a rare-disease drug to treat a smaller-than-expected pool of patients. Read More
from Investor's Business Daily
These Gene Therapy Stocks Are Spiking — Here's Why
Shares of gene therapy firms Sangamo Therapeutics and Sarepta Therapeutics popped Thursday on bullish expectations for their respective hemophilia A and Duchenne muscular dystrophy drugs. Read More
from Investor's Business Daily
More News
Read More
Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress
from GlobeNewswire News Releases
Goldman Drops Alnylam From Conviction List, But Continues To See 'Blockbuster Potential'
category Top Stories , Analyst Color , Benzinga , and 10 more.
from Benzinga
EpiPen shortage could turn into crisis as back-to-school season hits
category Medical Products , Pharmaceuticals , Health/Care , and 5 more.
from MarketWatch
Noteworthy ETF Inflows: XLV, JNJ, UNH, PFE
category ETFs
from ETF Channel
Pfizer Becomes #12 Most Shorted Dow Stock, Replacing Coca-Cola
category Stocks
from Market News Video
Verizon Communications Becomes #13 Most Shorted Dow Stock, Replacing Pfizer
category Stocks
from Market News Video
Ionis Pharmaceuticals' Royalties Rise, but So Do Expenses
category BIIB , IONS , PFE , and 3 more.
from Motley Fool
3 Beaten-Down Biotech Stocks: Can They Recover?
category IDRA , PFE , BMY , and 4 more.
from Motley Fool
Eli Lilly Stock History
category MDT , Market News , PFE , and 4 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.